A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Relapsed/Refractory DLBCL

  • Myron S. Czuczman
  • , Andrew Davies
  • , Kim M. Linton
  • , Nina Wagner-Johnston
  • , Randy D. Gascoyne
  • , David A. Eberhard
  • , Gilles Salles
  • , Thomas E. Witzig
  • , Pier Luigi Zinzani
  • , George W. Wright
  • , Louis M. Staudt
  • , Jacqueline Repici
  • , Dale Song
  • , Oliver Manzke
  • , Ian D. Lewis

Research output: Contribution to journalArticlepeer-review

Cite this